期刊文献+

围生期妇女骨量和骨代谢及其影响因素研究

Investigation on bone mass,bone metabolism and effect factors in women during perinatal period
原文传递
导出
摘要 目的:探讨围生期妇女骨量和骨代谢及其影响因素。方法:选取2008~2009年100例孕产妇为研究对象,将其设为观察组,选取同期的100例未孕妇女为对照组,将观察组孕早期、孕中期及孕后期和对照组的血清磷、钙、骨碱性磷酸酶、骨钙素、尿钙/肌酐及抗酒石酸酸性磷酸酶、雌二醇等进行检测及比较。结果:经研究比较发现,随着孕周的增加,观察组孕后期血清磷、钙、骨钙素降低,而则尿钙/肌酐、骨碱性磷酸酶、抗酒石酸酸性磷酸酶、雌二醇升高,孕后期与孕中期、孕前期及对照组比较,P<0.05或P<0.01,有统计学差异。结论:对于围生期妇女进行监测骨量和骨代谢较为重要,以便及时采取补钙措施。 Objective:To explore the bone mass,bone metabolism and effect factors in women during perinatal period.Methods:100 pregnant women were selected as observation group from 2008 to 2009,100 non-pregnant women synchronization were selected as control group,The serum levels of phosphorus,calcium,bone alkaline phosphatase,osteocalcin,urinary calcium/creatinine,tartrate-resistant acid phosphatase and estradiol in observation group of early,second trimester and late pregnancy and control group were detected and compared.Results:With the increase of gestational age,the serum levels of phosphorus,calcium and osteocalcin in observation group of late pregnancy decreased,while the serum levels of urinary calcium/creatinine,bone alkaline phosphatase,tartrate-resistant acid phosphatase and estradiol increased,there was significant difference among observation group of early,second trimester and late pregnancy and control group (P〈0.05 or P〈0.01).Conclusion:For women during perinatal period,the monitoring of bone mass and bone metabolism is important,in order to take measures to supply calcium.
作者 李银红
出处 《中国妇幼保健》 CAS 北大核心 2010年第22期3104-3105,共2页 Maternal and Child Health Care of China
关键词 围生期 骨量 骨代谢 研究 Perinatal period Bone mass Bone metabolism Study
  • 相关文献

参考文献5

二级参考文献25

  • 1张林.骨质疏松大鼠运动模型的建立与训练效果评定[J].体育科学,1999,19(6):72-76. 被引量:7
  • 2张林.健骨运动处方的研究与应用[J].体育科学,1999,19(5):50-54. 被引量:21
  • 3吴德生 董奇男 等.在致畸研究中小鼠胎鼠发育迟缓的评价指标[J].四川医学院学报,1984,15(1):59-63.
  • 4乔伟伟 许兰文.营养性骨质疏松动物模型的实验研究[J].营养学报,1999,2:240-240.
  • 5秦林林,陈金标,龚海洋,马海波,葛崇华,张卫.不同月龄雌性大鼠骨质疏松模型研究[J].中日友好医院学报,1997,11(1):6-9. 被引量:31
  • 6Food and Drug Administration. Guidelines for preclinical and clinical evaluation of agents used in the prevention and treatment of postmenopausal osteoporosis: Division of metabolism and endocrine drug[R]. products Draft, Appril, 1994.
  • 7日本厚生省.关于骨质疏松症治疗药物临床评价方法的指导原则[R].,平成7年1995..
  • 8Obenmayer P B, Chararas C,Kotschan S,et al. Genetic backgroud of osteoporosis [J]. Acta Med Austriaca, 2000, 27(1): 18 -20.
  • 9ErbenR G, Eberle J,Stahr K, et al. Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study[J]. J Bone Miner Res,2000,15:1085 - 1098.
  • 10Brighton C T. Treat ment of sciatic denervation disuse osteoporosis in the rat with capacitively coupled electrical stimulation[J].J Bone Joint Surg(AM), 1985,67:1022 - 1025.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部